BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Merck Unveils Promising Four-Year Safety and Efficacy Data for Evobrutinib, Investigational BTK Inhibitor in RMS

Data from the ongoing Phase II extension showed treatment benefits of evobrutinib were maintained over four years and remained consistent with the effica...

February 27, 2023 | News

SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent

SN514 hydrogel is a topical debridement product designed to remove eschar rapidly and effectively from severe burn wounds and chronic ulcers, including p...

February 24, 2023 | News

RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

The clinical trial aims to evaluate three of RVAC's COVID-19 vaccine candidates that include one against the ancestral strain, one against an Omicron strai...

February 21, 2023 | News

Global Sarcoma Therapy Now Approved for New Zealand Patients

Globally regarded soft-tissue sarcoma therapy has been approved by Medsafe for New Zealand patients YONDELIS® (trabectedin) demonstra...

February 18, 2023 | News

Oxford Nanopore Technologies teams up with UPS Healthcare to accelerate delivery of next-generation DNA sequencing technology

Oxford Nanopore Technologies today announced an extension of its collaboration with UPS Healthcare to accelerate the delivery of Oxford Nanopore DNA/RNA se...

February 16, 2023 | News

Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides

The collaboration will continue to leverage Sentia’s proprietary peptide-based platform and Neurocrine’s drug development expertise in CR...

February 15, 2023 | News

Eurofins Discovery Collaborating with Invasight on Cancer Therapies

Invasight is teaming with Eurofins Discovery's DiscoveryOne™, an integrated drug discovery platform that provides expert comprehensive support t...

February 15, 2023 | News

Gilead to present data at APASL 2023 on effective models for monitoring and treating hepatitis C and efficacy of antiviral treatments for HIV-1 and HBV-coinfected adults

-- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with ...

February 15, 2023 | News

STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option

Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...

February 13, 2023 | News

HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities

HanAll will invest in Interon Laboratories, a preclinical-stage biotechnology company focused on treating complex neurological disorders Interon is deve...

February 13, 2023 | News

MedHQ Partners with Avanza Healthcare Strategies

MedHQ, a leading provider of technology-enabled expert services including human resources, staffing, and financial management to outpatient healthcar...

February 10, 2023 | News

Everest Medicines Announces South Korea Grants Fast Track Review Designation to Nefecon for the Treatment of Primary IgA Nephropathy

This demonstrates the urgent unmet medical needs for Nefecon, as Everest also received Priority Review status for the New Drug Application (NDA) of Nefecon...

February 10, 2023 | News

EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis

ROP is a leading cause of childhood blindness worldwide Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug...

February 09, 2023 | News

Tavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos&r...

February 07, 2023 | News

Stay Connected